Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   537,854    

Indirect Shares

   247,533      
Direct Value   $43,021,652    

Indirect Value

   $21,938,850      
Total Shares   785,387      
Total Value   $64,960,502      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,495 Incyte Corp $889,298 Immunome Inc. $103,945 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,495 Incyte Corp $889,298 Immunome Inc. $103,945
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    851         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 31 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-12-16 4 OE $37.46 $224,760 D/D 6,000 309,689 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-12-16 4 AS $84.68 $508,080 D/D (6,000) 303,689 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-12-21 4 A $89.22 $8,922 D/D 100 303,789 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-01-12 4 AS $89.00 $445,000 D/D (5,000) 303,789 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-01-12 4 OE $37.46 $187,300 D/D 5,000 308,789 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-01-13 4 OE $37.46 $187,300 D/D 5,000 308,789 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-01-13 4 AS $87.86 $439,300 D/D (5,000) 303,789 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-03-08 4 A $0.00 $0 D/D 34,780 338,569 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-03-10 4 OE $37.46 $561,900 D/D 15,000 353,569 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-03-10 4 AS $77.57 $1,163,550 D/D (15,000) 338,569 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-03-11 4 AS $77.81 $1,167,150 D/D (15,000) 338,569 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-03-11 4 OE $37.46 $561,900 D/D 15,000 353,569 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-03-15 4 A $0.00 $0 D/D 40,280 378,849 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-03-15 4 D $78.27 $2,998,211 D/D (38,306) 340,543 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-03-16 4 D $80.72 $448,803 D/D (5,560) 334,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-14 4 OE $37.46 $374,600 D/D 10,000 344,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-14 4 AS $83.66 $836,600 D/D (10,000) 334,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-18 4 AS $81.91 $1,638,200 D/D (20,000) 334,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-18 4 OE $37.46 $749,200 D/D 20,000 354,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-28 4 OE $37.46 $749,200 D/D 20,000 354,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-28 4 AS $83.79 $1,675,800 D/D (20,000) 334,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-29 4 A $62.41 $21,281 D/D 341 335,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-29 4 OE $37.46 $187,300 D/D 5,000 339,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-29 4 AS $81.95 $409,750 D/D (5,000) 334,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-05-05 4 OE $37.46 $374,600 D/D 10,000 345,324 0 -
  851  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31  32   33   34   35      
  Page 31 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us